Safety and Effectiveness of Two Doses of ABT-874 as Compared to Placebo in Subjects With Multiple Sclerosis (MS)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2004
The objective of the trial is to study the safety and effectiveness of ABT-874 administered weekly or every other week in patients with relapsing remitting and secondary progressive multiple sclerosis as compared to placebo. Effectiveness will be measured based on MRI scans done periodically throughout the study.
Epistemonikos ID: cd65bdce7f4623b2ec409f44b33ee04f285b783a
First added on: Mar 31, 2022